Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature”
- 4 May 2021
- journal article
- correction
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 40 (7), 3025
- https://doi.org/10.1007/s10067-021-05741-4
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Comment on “Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature”Clinical Rheumatology, 2021
- Rebuttal letter on “Comment on Tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature”Clinical Rheumatology, 2021
- Long term inhibition of hip joint damage under tumor necrosis factor-alpha inhibitors in spondyloarthritisInternational Immunopharmacology, 2020